VOYA Investment Management
CARM

VOYA Investment Management’s Carisma Therapeutics CARM Stock Holding History

VOYA Investment Management’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,822
Closed -$31.7K – 2800
2023
Q4 		$31.7K Hold
10,822
– – ﹤0.01% 2885
2023
Q3 		$45.8K Hold
10,822
– – ﹤0.01% 2863
2023
Q2 		$94.9K Buy
+10,822
New +$58.9K ﹤0.01% 2804
2022
Q2 		– Sell
-4,178
Closed -$50K – 2787
2022
Q1 		$50K Buy
4,178
+834
+25% +$11.6K ﹤0.01% 2592
2021
Q4 		$55K Sell
3,344
-50
-1% -$1.01K ﹤0.01% 2738
2021
Q3 		$54K Hold
3,394
– – ﹤0.01% 2797
2021
Q2 		$314K Buy
+3,394
New +$216K ﹤0.01% 2352

Other funds holding CARM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
TOTUOP
Trustees of The University of Pennsylvania Philaldelphia, Pennsylvania $297M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

VOYA Investment Management's CARM Position: Q1 2024 in Review

VOYA Investment Management sold out of Carisma Therapeutics (CARM) in Q1 2024, closing a stake of 10,822 shares — an estimated $31.7K sold.

VOYA Investment Management first reported a position in CARM in Q2 2021 and held it in 7 quarters. The position peaked at $314K in Q2 2021. 51 funds tracked by Wall St. Rank hold CARM as of Q1 2024.

  • VOYA Investment Management reported no remaining Carisma Therapeutics position as of Q1 2024 after selling out during the quarter.
  • VOYA Investment Management sold 10,822 Carisma Therapeutics shares in Q1 2024, an estimated $31.7K.
  • VOYA Investment Management first reported a position in Carisma Therapeutics in Q2 2021 and held it in 7 quarters.
  • VOYA Investment Management's Carisma Therapeutics position peaked at $314K in Q2 2021.
  • 51 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q1 2024.

Based on VOYA Investment Management's 13F filing for Q1 2024, filed 15 May 2024.